FutureFuel Releases Third Quarter and Nine-Month 2018 Results

FutureFuel Third Quarter Net Income of $9.4 Million

Reports Net Income of $9.4 Million or $0.22 per Diluted Share, and Adjusted EBITDA of $13.7 Million

CLAYTON, Mo., Nov. 09, 2018 (GLOBE NEWSWIRE) — FutureFuel Corp. (NYSE:FF) (“FutureFuel”), a manufacturer of custom and performance chemicals and biofuels, today announced financial results for the third quarter and the nine months ended September 30, 2018.

Third Quarter 2018 Financial Highlights (all comparisons are with the third quarter of 2017)

  • Revenues were $81.4 million, up 4.9% from $77.6 million
  • Adjusted EBITDA was $13.7 million, up 43.0% from $9.6 million
  • Net income increased to $9.4 million, or $0.22 per diluted share, from $3.3 million, or $0.08 per diluted share.

Nine Month 2018 Financial Highlights (all comparisons are with the first nine months of 2017)

  • Revenues were $225.5 million, up 12.9% from $199.8 million
  • EBITDA was $62.9 million, up 265.8% from $17.2 million
  • Net income increased to $51.3 million, or $1.17 per diluted share, from $7.6 million, or $0.17 per diluted share.

“We saw strong demand across the board for our products and services in the third quarter. Combined with our solid operational performance, we were able to realize continued year on year growth in both our chemical and biodiesel segments. As we approach the end of the year, we remain in limbo with regard to reinstatement of the Blenders Tax Credit for 2018 and forward into 2019. Our entire industry would benefit from certainty over this issue,” said Tom McKinlay, Chief Operating Officer for FutureFuel Corp.

2018 Regular Cash Dividends

FutureFuel paid a normal quarterly dividend of $0.06 per share in the third quarter of 2018.  The remaining quarterly dividends of $0.06 per share will be paid in December.

Financial Overview and Key Operating Metrics

Financial and operating metrics, which include non-GAAP financial measures, include dollars in thousands, except per share amounts:

FutureFuel Corp.
Certain Financial and Operating Metrics
(Unaudited)

  Three months ended September 30,
          Dollar   %
  2018   2017   Change   Change
Revenues $   81,422   $   77,606   $   3,816     4.9 %
Income from operations $   10,229   $   3,200   $   7,029     219.7 %
Net income $   9,445   $   3,334   $   6,111     183.3 %
Earnings per common share:              
Basic $   0.22   $   0.08   $   0.14     175.0 %
Diluted $   0.22   $   0.08   $   0.14     175.0 %
Capital expenditures and intangibles (net of customer reimbursements and regulatory grants) $   642   $   856   $   (214 )   (25.0 %)
Adjusted EBITDA $   13,661   $   9,553   $   4,108     43.0 %
               
  Nine months ended September 30,
          Dollar   %
  2018   2017   Change   Change
Revenues $   225,505   $   199,765   $   25,740     12.9 %
Income from operations $   50,636   $   6,049   $   44,587     737.1 %
Net income $   51,322   $   7,564   $   43,758     578.5 %
Earnings per common share:              
Basic $   1.17   $   0.17   $   1.00     588.2 %
Diluted $   1.17   $   0.17   $   1.00     588.2 %
Capital expenditures and intangibles (net of customer reimbursements and regulatory grants) $   1,539   $   2,413   $   (874 )   (36.2 %)
Adjusted EBITDA $   62,926   $   17,201   $   45,725     265.8 %
                         

Financial and Business Summary

Consolidated sales revenue in the three and nine months ended September 30, 2018 increased 4.9% or $3,816 and 12.9% or $25,740, compared to the three and nine months ended September 30, 2017. The current three-month period was benefited $6,086 from higher biofuel prices and unfavorably affected by a volume reduction in pipeline trades.  In the first nine months, sales revenue benefited from strong demand in the Ag chemical and energy markets with higher sales volumes and prices in both segments.  Within the chemical segment, sales volume/product mix improved 11.0% or $8,543 in addition to an increase of $2,212 from higher average selling prices.  The price increases were primarily from higher prices indexed to higher raw material prices.  Within the biofuel segment, sales revenue increased $9,745 in the nine-month period from improved sales volumes and product mix and $5,240 from higher average selling prices experienced in the fuel industry.  Negatively influencing this price effect was the retroactive reinstatement of the 2017 blenders’ tax credit (BTC) passed into law on February 9, 2018.
    
Gross profit in the three and nine months ended September 30, 2018 increased $7,127 and $44,977 compared to the three months and nine months ended September 30, 2017. The three-month increase was primarily from stronger margins in the biofuel segment.  The nine-month increase was primarily from improved margins in the biofuel segment from the BTC which expired on December 31, 2016 and was retroactively reinstated for 2017 (but, not beyond 2017) on February 9, 2018 resulting in the benefit being recognized in 2018. Also benefiting gross profit in the nine-month period was increased sales volumes in both the chemicals and biofuels segments.  

Gross profit was additionally benefited in the three and nine months ended September 30, 2018, as compared to the prior year period, by the adjustment in the carrying value of our inventory as determined utilizing the LIFO method of inventory accounting.  The change in this adjustment decreased gross profit $443 in the three months ended September 30, 2018 and increased gross profit $2,708 in the nine months ended September 30, 2018 as compared to the three and nine months ended September 30, 2017.  This LIFO adjustment did not result in a lower of cost or market adjustment in the three and nine months ended September 30, 2018 and 2017.   Please see Note 3 for additional discussion.

Lastly, gross profit was favorably impacted by the change in the unrealized and realized activity in derivative instruments with a loss of $676 in the three months ended September 30, 2018, as compared to a loss of $3,314 in the prior year period.  In the nine-month period, gross profit was impacted negatively by the change in unrealized and realized activity in derivative instruments with a loss of $3,947, as compared to a loss of $1,511, in the prior year period. 

Net Income

Net income for the three and nine months ended September 30, 2018 increased $6,111 and $43,758 as compared to the same periods in 2017. The increase was from stronger sales volumes, a 14% reduction in the federal statutory tax rate, and biodiesel tax credits and incentives that were reinstated in the three months ended March 31, 2018 that were not in effect for 2017. 

Capital Expenditures

Capital expenditures and intangibles were $3,084 in the first nine months of 2018, compared with $2,614 in the same period in 2017. FutureFuel was reimbursed for a portion of these expenditures by certain customers as summarized in the following table.

  Nine months ended September 30,
  2018   2017
Cash paid for capital expenditures and intangibles $ 3,084     $ 2,614  
Cash received as reimbursement of capital expenditures $ (1,545 )   $ (201 )
Cash paid, net of reimbursement, for capital expenditures $ 1,539     $ 2,413  
               

Cash and Cash Equivalents and Marketable Securities

Cash and cash equivalents and marketable securities totaled $302,450 as of September 30, 2018, compared with $235,326 as of December 31, 2017.

About FutureFuel

FutureFuel is a leading manufacturer of diversified chemical products, specialty chemical products, and biofuel products. In its chemicals business, FutureFuel manufactures specialty chemicals for specific customers (“custom chemicals”) as well as multi-customer specialty chemicals (“performance chemicals”). FutureFuel’s custom chemicals product portfolio includes a bleach activator for a major detergent manufacturer, proprietary herbicide and intermediates for major life sciences companies, and chlorinated polyolefin adhesion promoters and antioxidant precursors for a major chemical company. FutureFuel’s performance chemicals product portfolio includes polymer (nylon) modifiers and several small-volume specialty chemicals for diverse applications. FutureFuel’s biofuels segment primarily produces and sells biodiesel to its customers. Please visit www.futurefuelcorporation.com for more information.

Forward-Looking Statements

This document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements deal with FutureFuel’s current plans, intentions, beliefs,   and expectations, and statements of future economic performance. Statements containing such terms as “believe,” “do not believe,” “plan,” “expect,” “intend,” “estimate,” “anticipate,” and other phrases of similar meaning are considered to contain uncertainty and are forward-looking statements. In addition, from time to time FutureFuel or its representatives have made or will make forward-looking statements orally or in writing. Furthermore, such forward-looking statements may be included in various filings that the company makes with United States Securities and Exchange Commission (the “SEC”), in press releases, or in oral statements made by or with the approval of one of FutureFuel’s authorized executive officers.

These forward-looking statements are subject to certain known and unknown risks and uncertainties, as   well as assumptions that could cause actual results to differ materially from those reflected in these forward-looking statements. Factors that might cause actual results to differ include, but are not limited to, those set forth under the headings “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in FutureFuel’s Form 10-K Annual Report for the year ended December 31, 2017 and in its future filings made with the SEC. An investor should not place undue reliance on any forward-looking statements contained in this document, which reflect FutureFuel management’s opinions only as of their respective dates. Except as required by law, the company undertakes no obligation to revise or publicly release the results of any revisions to forward-looking statements. The risks and uncertainties described in this document and in current and future filings with the SEC are not the only ones faced by FutureFuel. New factors emerge from time to time, and it is not possible for the company to predict which will arise. There may be additional risks not presently known to the company or that the company currently believes are immaterial to its business. In addition, FutureFuel cannot assess the impact of each factor on its business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. If any such risks occur, FutureFuel’s business, operating results, liquidity, and financial condition could be materially affected in an adverse manner. An investor should consult any additional disclosures FutureFuel has made or will make in its reports to the SEC on Forms 10-K, 10-Q, and 8-K, and any amendments thereto. All subsequent written and oral forward-looking statements attributable to FutureFuel or persons acting on its behalf are expressly qualified in their entirety by the cautionary statements contained in this document.

Non-GAAP Financial Measures

In this press release, FutureFuel used adjusted EBITDA as a key operating metric to measure both performance and liquidity. Adjusted EBITDA is a non-GAAP financial measure. Adjusted EBITDA is not a substitute for operating income, net income, or cash flow from operating activities (each as determined in accordance with GAAP), as a measure of performance or liquidity. Adjusted EBITDA has limitations as an analytical tool, and should not be considered in isolation or as a substitute for analysis of results as reported under GAAP. FutureFuel defines adjusted EBITDA as net income before interest, income taxes, depreciation, and amortization expenses, excluding, when applicable, non-cash share-based compensation expense, public offering expenses, acquisition-related transaction costs, purchase accounting adjustments, loss on disposal of property and equipment, gains or losses on derivative instruments, other non-operating income or expense. Information relating to adjusted EBITDA is provided so that investors have the same   data that management employs in assessing the overall operation and liquidity of FutureFuel’s business. FutureFuel’s calculation of adjusted EBITDA may be different from similarly titled measures used by other companies; therefore, the results of its calculation are not necessarily comparable to the results of other companies.

Adjusted EBITDA allows FutureFuel’s chief operating decision makers to assess the performance and liquidity of FutureFuel’s business on a consolidated basis to assess the ability of its operating segments to produce operating cash flow to fund working capital needs, to fund capital expenditures, and to pay dividends. In particular, FutureFuel management believes that adjusted EBITDA permits a comparative assessment of FutureFuel’s operating performance and liquidity, relative to a performance and liquidity based on GAAP results, while isolating the effects of depreciation and amortization, which may vary among its operating segments without any correlation to their underlying operating performance, and of non-cash stock-based compensation expense, which is a non-cash expense that varies widely among similar companies, and gains and losses on derivative instruments, whose immediate recognition can cause net income to be volatile from quarter to quarter due to the timing of the valuation change in the derivative instruments relative to the sale of  biofuel.

A table included in this earnings release reconciles adjusted EBITDA with net income, the most directly comparable GAAP performance financial measure, and a table reconciles adjusted EBITDA with cash flows from operations, the most directly comparable GAAP liquidity financial measure.

FutureFuel Corp.
Condensed Consolidated Balance Sheets
(Dollars in thousands) 

  (Unaudited)    
  September 30, 2018   December 31, 2017
Assets      
Cash and cash equivalents $ 199,348   $ 114,627
Accounts receivable, net of allowances for bad debt of $0 and $0, at September 30, 2018 and December 31, 2017, respectively   21,489     22,138
Inventory   48,005     43,754
Marketable securities   103,102     120,699
Other current assets   1,782     9,140
Total current assets   373,726     310,358
Property, plant and equipment, net   104,254     109,735
Other assets   5,225     5,470
Total noncurrent assets   109,479     115,205
Total Assets $ 483,205   $ 425,563
Liabilities and Stockholders’ Equity      
Accounts payable $ 34,546   $ 19,579
Dividends payable   2,626     10,498
Other current liabilities   14,967     5,204
Total current liabilities   52,139     35,281
Deferred revenue – long-term   14,651     16,522
Other noncurrent liabilities   18,567     22,164
Total noncurrent liabilities   33,218     38,686
Total liabilities   85,357     73,967
Commitments and contingencies:      
Preferred stock, $0.0001 par value, 5,000,000 shares authorized, none issued and outstanding      
Common stock, $0.0001 par value, 75,000,000 shares authorized, 43,743,243 and 43,741,670, issued and outstanding as of September 30, 2018 and December 31, 2017, respectively   4     4
Accumulated other comprehensive income   124     8,433
Additional paid in capital   282,109     281,964
Retained earnings   115,611     61,195
Total Stockholders’ Equity   397,848     351,596
Total Liabilities and Stockholders’ Equity $ 483,205   $ 425,563
           

FutureFuel Corp.
Condensed Consolidated Statements of Operations
and Comprehensive Income
(Dollars in thousands, except per share amounts)
(Unaudited)

  Three months ended September 30,   Nine months ended September 30,
  2018   2017   2018   2017
Revenue $   81,422     $   77,606     $   225,505     $   199,765  
Cost of goods sold and distribution     68,769         72,080         167,074         186,311  
Gross profit     12,653         5,526         58,431         13,454  
Selling, general, and administrative expenses     1,547         1,391         4,952         4,870  
Research and development expenses     877         935         2,843         2,535  
      2,424         2,326         7,795         7,405  
Income from operations     10,229         3,200         50,636         6,049  
Other income, net     3,228         1,864         3,022         4,890  
Income before income taxes     13,457         5,064         53,658         10,939  
Provision for income taxes     4,012         1,730         2,336         3,375  
Net income $   9,445     $   3,334     $   51,322     $   7,564  
               
Earnings per common share              
Basic $   0.22     $   0.08     $   1.17     $   0.17  
Diluted $   0.22     $   0.08     $   1.17     $   0.17  
Weighted average shares outstanding              
Basic     43,724,195         43,705,234        43,719,215        43,662,672  
Diluted     43,732,920         43,714,753        43,725,370        43,671,420  
               
Comprehensive Income              
Net income $   9,445     $   3,334     $   51,322     $   7,564  
Other comprehensive income from unrealized                              
net gain on available-for-sale securities     (27 )       1,006         (19 )       7,102  
Income tax effect     6         (353 )       4         (2,490 )
Total unrealized (loss)/gain, net of tax     (21 )       653         (15 )       4,612  
Comprehensive income $   9,424     $   3,987     $   51,307     $   12,176  
                               

FutureFuel Corp.
Consolidated Statements of Cash Flows
For the Nine Months Ended September 30, 2017 and 2016
(Dollars in thousands)
(Unaudited)

  Nine months ended September 30,
  2018   2017
Cash flows provided by operating activities      
Net income $   51,322     $   7,564  
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation     8,244         8,735  
Amortization of deferred financing costs     108         109  
Benefit for deferred income taxes     (3,609 )       (1,303 )
Change in fair value of equity securities     5,597         –  
Change in fair value of derivative instruments     (2,290 )       (60 )
Other than temporary impairment of marketable securities     –         177  
Impairment of fixed assets     258         28  
(Gain)/loss on the sale of investments     (2,324 )       366  
Stock based compensation     321         878  
Loss on disposal of fixed assets     41         145  
Noncash interest expense     22         20  
Changes in operating assets and liabilities:      
Accounts receivable     3,031         3,081  
Accounts receivable – related parties     (2,382 )       (1,181 )
Inventory     (4,251 )       8,570  
Income tax receivable     6,458         5,546  
Prepaid expenses     1,190         1,152  
Prepaid expenses – related parties     –         (4 )
Accrued interest on marketable securities     9         22  
Other assets     (256 )       37  
Accounts payable     13,018         1,425  
Accounts payable – related parties     1,949         2,780  
Accrued expenses and other current liabilities     5,385         1,587  
Accrued expenses and other current liabilities – related parties     –         (142 )
Deferred revenue     (2,672 )       (3,220 )
Other noncurrent liabilities     –         128  
Net cash provided by operating activities     79,169         36,440  
Cash flows from investing activities      
Collateralization of derivative instruments   2,384       (760 )
Purchase of marketable securities   (19,664 )     (25,795 )
Proceeds from the sale of marketable securities   33,942       14,913  
Proceeds from the sale of fixed assets   22       4  
Capital expenditures   (3,084 )     (2,614 )
Net cash provided by/(used in) investing activities   13,600       (14,252 )
Cash flows from financing activities      
Minimum tax withholding on stock options exercised and awards vested   (176 )     (121 )
Excess tax benefits associated with stock options and awards         (31 )
Payment of dividends   (7,872 )     (108,063 )
Net cash used in financing activities   (8,048 )     (108,215 )
Net change in cash and cash equivalents   84,721       (86,027 )
Cash and cash equivalents at beginning of period   114,627       199,272  
Cash and cash equivalents at end of period $ 199,348     $ 113,245  
       
Cash paid for interest $     $  
Cash paid for income taxes $ 1,506     $ 55  
               

FutureFuel Corp.
Reconciliation of Non-GAAP Financial Measure to Financial Measure
(Dollars in thousands)
(Unaudited)

Reconciliation of Adjusted EBITDA to Net Income

  Three months ended September 30,   Nine months ended September 30,
  2018   2017   2018   2017
Adjusted EBITDA $ 13,661     $ 9,553     $ 62,926     $ 17,201  
Depreciation   (2,732 )     (2,927 )     (8,244 )     (8,735 )
Non-cash stock-based compensation   (107 )     (128 )     (321 )     (878 )
Interest and dividend income   2,543       1,965       6,688       5,679  
Non-cash interest expense (including amortization of deferred financing costs)   (43 )     (43 )     (130 )     (129 )
Losses on disposal of property and equipment   (4 )     (68 )     (41 )     (145 )
Losses on derivative instruments   (676 )     (3,314 )     (3,947 )     (1,511 )
Gains/(losses) on marketable securities   815       26       (3,273 )     (543 )
Provision for income taxes   (4,012 )     (1,730 )     (2,336 )     (3,375 )
Net income $ 9,445     $ 3,334     $ 51,322     $ 7,564  
                               

Reconciliation of Adjusted EBITDA to Net Cash Provided by Operating Activities

  Nine months ended September 30,
  2018   2017
Adjusted EBITDA $ 62,926     $ 17,201  
Benefit for deferred income taxes   (3,609 )     (1,303 )
Impairment of fixed assets   258       28  
Interest and dividend income   6,688       5,679  
Provision for income taxes   (2,336 )     (3,375 )
Losses on derivative instruments   (3,947 )     (1,511 )
Change in fair value of derivative instruments   (2,290 )     (60 )
Changes in operating assets and liabilities, net   21,479       19,781  
Net cash provided by operating activities $ 79,169     $ 36,440  
               

FutureFuel Corp.
Condensed Consolidated Segment Income
(Dollars in thousands)
(Unaudited) 

  Three months ended September 30,   Nine months ended September 30,
  2018   2017   2018   2017
Revenue              
Custom chemicals $   23,973     $   23,593     $   74,465     $   65,189  
Performance chemicals     4,049         4,574         14,165         12,686  
Chemicals revenue     28,022         28,167         88,630         77,875  
Biofuels revenue     53,400         49,439         136,875         121,890  
Total Revenue $   81,422     $   77,606     $   225,505     $   199,765  
               
Segment gross profit/(loss)              
Chemicals $   8,898     $   8,060     $   24,470     $   20,401  
Biofuels     3,755         (2,534 )       33,961         (6,947 )
Total gross profit     12,653         5,526         58,431         13,454  
Corporate expenses     (2,424 )       (2,326 )       (7,795 )       (7,405 )
Income before interest and taxes     10,229         3,200         50,636         6,049  
Interest and other income     3,358         1,965         6,688         5,679  
Interest and other expense     (130 )       (101 )       (3,666 )       (789 )
Provision for income taxes     (4,012 )       (1,730 )       (2,336 )       (3,375 )
Net income $   9,445     $   3,334     $   51,322     $   7,564  
                               

Depreciation is allocated to segment costs of goods sold based on plant usage. The total assets and capital expenditures of FutureFuel have not been allocated to individual segments as large portions of these assets are shared to varying degrees by each segment, causing such an allocation to be of little value.

COMPANY CONTACT
FutureFuel Corp.
Tom McKinlay
(314)854-8352
www.futurefuelcorporation.com

Share this post